Vitalls

AI-powered digital health passport for secure, patient-owned medical record management and sharing.

Cover Block

Open sources

Field	Detail
Name	Vitalls
Tagline	AI-powered digital health passport for secure, patient-owned medical record management and sharing.
Headquarters	United Arab Emirates [Wamda, October 2026]
Founded	2023 [Wamda, October 2026]
Stage	Seed [Wamda, October 2026]
Business model	B2C
Industry	Healthtech [Wamda, October 2026]
Technology	AI / Machine Learning [Vitalls, retrieved 2025]
Geography	Middle East / North Africa
Growth profile	Venture Scale
Founding team	Solo Founder [Wamda, October 2026]
Founder	Mehdi Bouchnak [Wamda, October 2026]
Funding label	Seed [Wamda, October 2026]
Total disclosed	$1,500,000 [Wamda, October 2026]

What an Investor Needs First

PUBLIC Vitalls is building a patient-controlled digital health passport for storing, organizing, and sharing medical records, and it merits investor attention now because the company has just disclosed a $1.5 million seed investment commitment from EST Growmore at a moment when cross-border record portability remains a real pain point in MENA healthcare [Wamda, October 2026] [Sharikat Mubasher, October 2026] [The Startup Scene, October 2026]. The company was founded in the UAE in 2023 by Mehdi Bouchnak, with public coverage consistently describing Vitalls as an AI-powered healthtech startup aimed at helping individuals and families manage fragmented records across providers and countries [Wamda, October 2026] [Arab Founders, October 2026].

The product is positioned less as a provider-side electronic health record and more as a consumer-held record layer: users can upload medical files, the system organizes them, and Vitalls says its intelligence layer can digitize documents and extract information for easier retrieval and sharing with healthcare providers [Vitalls, retrieved 2025] [Wamda, October 2026]. That framing is the clearest point of differentiation in the current public record, particularly for patients whose care histories span multiple systems, languages, or geographies [The Startup Scene, October 2026] [Jawlah, October 2026].

On team, the verified public record is still thin. Bouchnak is identified as founder and CEO across the available materials, while broader claims about his prior operating depth come primarily from company-linked descriptions rather than independent reporting, which limits how much weight investors should place on them at this stage [Wamda, October 2026] [Vitalls, October 2026].

Funding is straightforward in outline but worth reading carefully in wording. Vitalls announced a $1.5 million seed commitment from EST Growmore Pte. Ltd., with several outlets also noting an option for an additional $1 million; the distinction between committed capital and fully funded proceeds is material for underwriting near-term execution [Wamda, October 2026] [Sharikat Mubasher, October 2026] [Arab News, October 2026]. The business model is currently described as B2C, with public-facing messaging centered on individuals and families, while some coverage reports longer-term expansion toward businesses and institutions that need rapid access to health records [Vitalls, retrieved 2025] [Jawlah, October 2026].

Over the next 12 to 18 months, the public milestones to watch are basic but consequential: evidence of user adoption, proof that document digitization works reliably across messy real-world records, and any verified movement from consumer utility into institutional distribution or partnerships. Until those signals appear, the company reads as an interesting early seed bet on patient-owned health data portability, with the category appeal clearer than commercial traction [Vitalls, retrieved 2025] [Wamda, October 2026].

Partially corroborated -- Core company identity and funding are corroborated by multiple public sources, but several product and team details remain company-described or only partially independently verified.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	B2C
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Middle East / North Africa
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	$1,500,000 seed commitment disclosed [Wamda, October 2026]

Inside the Company

PUBLIC

Vitalls entered the public record as a UAE healthtech startup founded in 2023 by Mehdi Bouchnak, with a product centered on a patient-controlled digital health record rather than a provider-owned system [Vitalls, retrieved 2025]. The company’s own website describes the product as a "secure, patient-owned digital health passport" built to help users manage, protect, and share medical records, and its homepage shows distribution through both Google Play and the Apple App Store [Vitalls, retrieved 2025].

The chronology visible from public source material is still short, but it is concrete where it matters. By October 2026, Vitalls had announced a US$1.5 million seed investment commitment from EST Growmore Pte. Ltd. at the Abu Dhabi Future Health Summit, framing the capital as support for further development and rollout of the platform [Vitalls, October 2026]. That leaves a straightforward early-stage picture: founded in 2023 in the UAE, product live enough to be presented as an app on the company site, and first disclosed institutional backing announced in October 2026 [Vitalls, retrieved 2025] [Vitalls, October 2026].

Claim stands unchecked -- This section relies primarily on company website disclosures, with no cited state filing or independent registry evidence used here.

Under the Hood

Reported and inferred

Vitalls is building around a narrow but legible product idea: a patient-controlled record layer that sits with the user rather than with a hospital or insurer. Public materials describe the product as a digital health passport for storing, organizing, and sharing medical records, with the company emphasizing portability across providers and, in press coverage, across countries where records may sit in different formats and languages [Vitalls, retrieved 2025] [Wamda, October 2026] [The Startup Scene, October 2026]. That framing matters because it places Vitalls closer to a consumer health-data wallet than to a provider-side electronic health record system, a distinction also reflected in coverage that describes the product as patient-owned and aimed first at individuals and families [Vitalls, retrieved 2025] [Jawlah, October 2026].

The feature set that can be tied to public sources is still relatively basic, but it is concrete. On its website, Vitalls says users can upload medical data, after which the system organizes it; the company also says "Vitalls Intelligence" digitizes files and extracts information, and that users can share health information with healthcare providers when needed [Vitalls, retrieved 2025]. The site also positions the app for patients, doctors, and insurers in its metadata, though the visible product flow is centered on the patient as system of record [Vitalls, retrieved 2025]. Press reports add the problem statement, fragmented records across care settings and borders, but they do not verify named integrations, provider deployments, or a demonstrated enterprise workflow beyond sharing records outward from the user account [Wamda, October 2026] [Arab Founders, October 2026].

What remains unverified from public evidence is as important as what is visible. There is no confirmed public detail on the underlying AI architecture, data model, interoperability standards, regulatory clearances, security certifications, or live health-system integrations in the sources reviewed [Vitalls, retrieved 2025] [CB Insights, retrieved 2026]. That leaves the current public read as a consumer-facing records utility with AI-assisted digitization and extraction claims, not yet a fully evidenced infrastructure product. The product concept is understandable, and the user pain point is real, but the technical moat cannot be assessed confidently from the present record.

Claim stands unchecked -- Product functionality relies primarily on company website claims, with partial framing corroborated by Wamda and other October 2026 press coverage.

Market Research

Open sources This market matters now because cross-border care, patient mobility, and uneven health-record interoperability keep creating the same practical problem: patients still carry fragmented medical histories across providers, systems, and countries, and startups that make those records portable have a clearer wedge than broad provider-side software plays [The Startup Scene, October 2026].

The available public record does not provide a cited TAM, SAM, or SOM for Vitalls itself, and there is no named third-party market report in the source set that quantifies the company’s addressable segment. What can be said, conservatively, is that Vitalls is positioned in the overlap between consumer health record management and digital health information exchange, with a product framed as a patient-owned record rather than a hospital EHR replacement [Vitalls, retrieved 2025] [Wamda, October 2026]. That distinction matters because it places demand less on hospital procurement cycles and more on user need for storage, portability, and selective sharing across care settings [The SaaS News, October 2026] [Arab Founders, October 2026].

Demand drivers in the cited coverage are practical rather than speculative. Multiple reports describe the underlying problem as fragmented records spread across hospitals, clinics, labs, and national systems, with additional friction when records move across borders or exist in different formats and languages [The Startup Scene, October 2026] [Jawlah, October 2026] [Arab Founders, October 2026]. Vitalls' own product language also points to a workflow built around digitizing files, extracting information, and sharing records with providers when needed, which suggests a market opening wherever patients still rely on PDFs, paper files, or app-by-app record storage instead of a persistent longitudinal record [Vitalls, retrieved 2025].

Adjacent markets are easier to identify than hard market size. One substitute is the provider-controlled electronic health record, but the source set consistently positions Vitalls outside that category, as a user-held layer that sits across providers rather than inside one provider's stack [Wamda, October 2026] [Vitalls, retrieved 2025]. Other adjacent surfaces include emergency medical ID apps, consumer health vaults, insurer-facing record sharing, and broader digital identity tools for regulated data exchange, although the available sources do not confirm that Vitalls has commercialized each of those paths [Vitalls, retrieved 2025] [The SaaS News, October 2026].

Regulatory and macro forces cut both ways. On the supportive side, the product premise aligns with longstanding pressure for better continuity of care, patient access to records, and secure data portability, especially in regions with large expatriate populations and frequent multi-country care journeys [The Startup Scene, October 2026] [Arab News, October 2026]. On the constraining side, health data products tend to face country-by-country privacy, consent, storage, and interoperability requirements, and the current public materials do not establish how far Vitalls has progressed on those fronts beyond positioning itself as secure and patient-owned [Vitalls, retrieved 2025].

Market lens	Public evidence	Read-through for Vitalls
Core problem area	Fragmented records across providers and countries [The Startup Scene, October 2026] [Jawlah, October 2026]	Supports a portability-led wedge rather than a provider system replacement
Product category	Patient-owned digital health passport [Vitalls, retrieved 2025] [Wamda, October 2026]	Places the company closer to consumer health data management than hospital EHR software
Initial buyer surface	Individuals and families [Wamda, October 2026] [The SaaS News, October 2026]	Suggests a B2C entry point, with monetization still needing proof
Expansion adjacency	Businesses and institutions reportedly in scope [Jawlah, October 2026]	Indicates a possible B2B2C path, but public evidence is still early

The table shows a market thesis built on workflow pain and positioning, not on disclosed category metrics. That is workable at seed, but it also means the market case remains more qualitative than quantified in the current public record.

Partially corroborated -- Section relies on named public coverage and the company website for category framing, but no independent third-party market sizing report or confirmed numeric segmentation was available in the source set.

Competition and Substitutes

MIXED Vitalls is positioning itself less against hospital record systems than against consumer-controlled health record products and emergency medical ID tools, with a cross-border portability claim at the center of the pitch [Vitalls, retrieved 2025] [Wamda, October 2026] [The Startup Scene, October 2026].

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Vitalls	AI-powered digital health passport for individuals and families to store, organize, and share medical records	Seed, $1.5 million commitment announced October 2026	Patient-owned record with AI-assisted digitization and sharing workflow	[Wamda, October 2026] [Vitalls, retrieved 2025]
Citizen Health	Named competitor in patient-facing health record management	Not established in provided sources	Present in the same broad patient-controlled health data category	[CB Insights, retrieved 2026]
Medical ID	Named competitor in medical record / emergency information tools	Not established in provided sources	Likely adjacent substitute for portable health information access, based on category naming only	[CB Insights, retrieved 2026]
Health Bank One	Named competitor in health data portability / record access	Not established in provided sources	Present in the broader health data access category	[CB Insights, retrieved 2026]

The competitive map is narrower than the phrase digital health passport first suggests. On one side are incumbent provider-side systems, the electronic health record products used by hospitals and clinics, which Vitalls is not described as replacing [Wamda, October 2026]. On the other are consumer-facing challengers and adjacent substitutes, including the named competitors above, plus any tool that lets a patient surface critical health information quickly, even if that tool is lighter weight than a full record vault [CB Insights, retrieved 2026].

That distinction matters because Vitalls' public wedge is fragmentation across providers, countries, languages, and file formats, not provider workflow automation [The Startup Scene, October 2026]. If that problem statement is accurate, the closest competition is not only another startup with similar branding, but also the simpler alternative of patients keeping PDFs, phone notes, insurer documents, and app-based medical IDs in parallel. In practical terms, Vitalls has to beat both dedicated record platforms and the low-cost substitute of doing nothing more than storing documents across consumer apps.

The clearest edge visible today is product positioning rather than a verified moat. Vitalls says users can upload medical data, have the system organize it, digitize files, extract information, and share records with healthcare providers when needed [Vitalls, retrieved 2025]. That creates a cleaner narrative than a static emergency card product, especially for internationally mobile users, but the durability of that edge is still unproven because the public record does not yet show exclusive distribution, proprietary clinical integrations, regulatory clearances, or a named enterprise channel that would make switching harder [Wamda, October 2026] [Vitalls, October 2026].

The company's exposure is therefore straightforward. A named rival such as Citizen Health could be advantaged if it has already built stronger provider connectivity, a more mature user base, or clearer trust signals around handling sensitive records, though the provided sources do not verify those points directly [CB Insights, retrieved 2026]. Vitalls is also exposed to adjacent substitutes like Medical ID style tools if users decide that fast access to a narrow set of emergency data is sufficient and do not need a fuller longitudinal record [CB Insights, retrieved 2026].

Over the next 18 months, the most plausible competitive outcome turns on proof of real-world sharing behavior. Winner if X: Vitalls, if it can show that patients and families repeatedly use the product across borders or across fragmented care settings, because that would validate the passport framing and begin to separate it from simpler storage apps [The Startup Scene, October 2026] [Vitalls, retrieved 2025]. Loser if Y: Vitalls, if a competitor such as Health Bank One or Citizen Health pairs similar record portability with stronger institutional adoption, or if the category settles into a lighter-weight emergency ID use case where Medical ID style products remain good enough for most users [CB Insights, retrieved 2026].

Reasoned from indirect evidence -- Subject-company product claims rely heavily on the company website, and competitor identities come from CB Insights without corroborated funding, scale, or product-depth comparisons in the provided public sources.

Opportunity

Upside Case

PUBLIC The prize here is not a better records app, it is a patient-controlled identity and data layer for cross-border healthcare, a category that could matter far beyond a single consumer subscription if portability becomes the wedge rather than the feature [Vitalls, retrieved 2025] [The Startup Scene, October 2026] [Wamda, October 2026].

The headline opportunity is fairly specific. If Vitalls can turn a consumer-facing digital health passport into the default way individuals carry, organize, and permission their records across providers and geographies, it could become a control point in a fragmented part of healthcare that still lacks a broadly adopted patient-owned layer [Vitalls, retrieved 2025] [The Startup Scene, October 2026]. That outcome is still early, but it is not purely aspirational on the evidence available: the company is already framing the product around portability, secure sharing, and AI-assisted digitization of records, and outside coverage consistently describes the problem as fragmented medical information across systems, formats, and countries [Vitalls, retrieved 2025] [Wamda, October 2026] [Jawlah, October 2026] [Arab Founders, October 2026]. The October 2026 seed commitment also matters because it gives the company a first institutional backer around this thesis, even if the disclosed amount is a commitment rather than fully evidenced deployed capital [Wamda, October 2026] [Sharikat Mubasher, October 2026] [Vitalls, October 2026].

A credible upside case branches into a few distinct growth paths, and the public record supports plausibility more than certainty.

Scenario	What happens	Catalyst	Why it's plausible
Cross-border consumer wallet	Vitalls becomes a trusted record wallet for people who receive care across more than one country, starting with individuals and families and later monetizing continuity-of-care workflows	Wider patient demand for portable records, especially where records sit in different languages and formats	The company is explicitly positioned around cross-border portability, fragmented records, and patient ownership rather than provider-side EHR replacement [The Startup Scene, October 2026] [Vitalls, retrieved 2025] [Wamda, October 2026]
B2B2C through insurers and employers	Vitalls keeps the consumer interface but reaches scale through institutions that need immediate access to verified health information for members or employees	A partnership model with insurers, employers, or similar institutions that want faster record access without building their own stack	The homepage says the product is built for patients, doctors, and insurers, and external coverage reports plans to expand toward businesses and institutions [Vitalls, retrieved 2025] [Jawlah, October 2026] [The SaaS News, October 2026]
Records intelligence layer	Vitalls uses its digitization and extraction workflow to become the intake and normalization layer for messy medical documents, not just the storage destination	Product proof that AI-assisted extraction reduces friction enough to make onboarding records easier than incumbent manual processes	Vitalls publicly claims users can upload medical data and that its intelligence layer digitizes files and extracts information, which at least points to a workflow advantage if execution holds [Vitalls, retrieved 2025]

These scenarios point to the same compounding logic. A consumer who uploads records creates a usable personal archive; a useful archive makes sharing with clinicians or other institutions more natural; each sharing event makes the product more embedded in care workflows; and better digitization should reduce setup friction for the next user if the extraction layer improves over time [Vitalls, retrieved 2025]. The early public evidence of this flywheel is still limited to product positioning, not operating metrics, but the direction is coherent: organize records, extract key information, and make sharing simple enough that the passport becomes part of routine care rather than emergency backup [Vitalls, retrieved 2025] [Wamda, October 2026]. If that loop works, the defensibility would likely sit less in the model layer and more in accumulated user records, repeat sharing behavior, and institutional distribution relationships.

The size of the win is easiest to frame through market structure rather than current traction. CB Insights tracks Vitalls in a product and competitors set that includes Citizen Health, Medical ID, and Health Bank One, which suggests the company is pursuing a recognized patient-data management category rather than inventing an entirely new one [CB Insights]. No credible public market-cap or acquisition benchmark is established in the supplied materials, so any valuation translation has to stay conditional. In a scenario, not a forecast, where Vitalls becomes a meaningful regional patient-record platform with institutional distribution and a durable role in cross-border data portability, the outcome could extend well beyond the economics of a narrow B2C app because the product surface already points toward patients, doctors, and insurers rather than a single end market [Vitalls, retrieved 2025]. The gating issue is not whether the problem exists. The cited record shows that it does. The gating issue is whether Vitalls can convert that problem into a trusted network before larger healthcare or insurance incumbents make portability a bundled feature [The Startup Scene, October 2026] [Vitalls, October 2026].

Partially corroborated -- Section relies on one independent cluster of October 2026 funding and product coverage, plus company website claims for workflow details. Public upside framing is evidence-based, but no independent traction or market-size data was available in the supplied sources.

Sources